balance equationreview2025-09-30
Difference 14585000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$157.43M
Fiscal year ended 2026-09-30Net income
$42.24M
Fiscal year ended 2026-09-30Total assets
$979.82M
Fiscal year ended 2026-09-30Valuation, from the filing
| Public float | $2.10B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $40.86 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 13.7× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 3.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 3.4× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Valuation over time
13.7× earnings today, against a median of 9.5× across 10 years on record. Above its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-06-30 | $2.10B | 13.7× | |
| 2024-06-30 | $2.00B | 13.2× | |
| 2023-06-30 | $1.50B | 11.6× | |
| 2022-06-30 | $1.60B | 9.4× | |
| 2021-06-30 | $2.00B | 9.5× | |
| 2020-06-30 | $1.70B | 22.2× | |
| 2019-06-30 | $1.20B | 8.9× | |
| 2018-06-30 | $922.00M | 8.1× | |
| 2017-06-30 | $878.00M | 9.5× | |
| 2016-06-30 | $836.00M | 9.0× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Investment Advice filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| FCF margin | -22.7% | 7th | |
| Operating margin | 32.0% | 83th | |
| Net margin | 27.6% | 76th | |
| SBC / revenue | 8.3% | 71th | |
| CapEx / revenue | 1.1% | 59th | |
| Revenue YoY growth | 7.5% | 44th |
COHEN & STEERS, INC. (CNS) reported revenue of $157.43M and net income of $42.24M for the fiscal year ended 2026-09-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from COHEN & STEERS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Investment Advice.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157.43M | $152.73M | $145.64M | $143.80M | $141.72M | $136.13M | $134.47M | $139.78M | $133.20M | $121.72M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $51.06M | $52.78M | $50.12M | $40.31M | $48.90M | $43.33M | $45.20M | $49.34M | $44.87M | $38.40M |
| Net income | $42.24M | $49.34M | $42.37M | $34.88M | $41.71M | $36.85M | $39.78M | $45.82M | $39.67M | $31.77M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 52.11M | shares 51.86M | shares 51.60M | Unavailable | shares 51.57M | shares 51.47M | shares 51.42M | Unavailable | shares 51.43M | shares 50.77M |
| Pretax income | $56.00M | $72.01M | $57.20M | $42.29M | $55.56M | $53.83M | $52.95M | $55.70M | $67.58M | $40.96M |
| Income tax expense | $15.17M | $16.45M | Unavailable | Unavailable | $13.92M | $12.06M | Unavailable | $12.69M | $12.29M | $10.88M |
| Diluted EPS | $0.81 | $0.95 | $0.82 | Unavailable | $0.81 | $0.72 | $0.77 | Unavailable | $0.77 | $0.63 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $17.52M | $18.95M | $18.90M | $19.21M | $16.78M | $18.08M | $17.17M | $15.78M | $14.87M | $14.68M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $66.12M | $59.15M | $53.09M | $145.45M | $98.05M | $95.37M | $65.23M | $182.97M | $106.47M | $122.01M |
| Total assets | $979.82M | $900.98M | $854.73M | $876.69M | $801.61M | $751.02M | $834.86M | $812.37M | $727.79M | $784.05M |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $231.09M | $205.61M | $187.76M | $242.85M | $222.36M | $208.70M | $193.51M | $237.46M | $215.24M | $199.65M |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $681.24M | $654.26M | $623.30M | $611.04M | $564.67M | $541.07M | $519.64M | $521.44M | $498.06M | $469.83M |
| Temporary (mezzanine) equity | $67.49M | $41.10M | $43.67M | $22.80M | Unavailable | Unavailable | Unavailable | $53.46M | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | $79.78M | $68.33M | Unavailable | Unavailable | $74.39M | Unavailable | Unavailable |
| Goodwill | Unavailable | Unavailable | Unavailable | $18.79M | Unavailable | Unavailable | Unavailable | $17.51M | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $20.86M | $67.39M | -$51.36M | $1.06M | $55.08M | -$67.64M | -$108.95M | $34.83M | $25.62M | $31.37M |
| Capital expenditures | $879.00K | Unavailable | Unavailable | $282.00K | $2.49M | $2.13M | $1.08M | $1.68M | $1.41M | $4.24M |
| Investing cash flow | -$13.64M | -$35.06M | -$24.81M | $39.08M | -$35.26M | $2.53M | $2.00M | $23.11M | -$39.08M | -$74.38M |
| Financing cash flow | -$1.98M | -$26.93M | -$13.65M | $7.58M | -$17.01M | $93.81M | -$10.54M | $13.11M | $3.56M | $65.76M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $10.77M | $11.29M | $10.79M | $10.08M | $12.34M | $12.16M | $11.38M | $10.87M | $14.52M | $13.92M |
| Common dividends paid | $34.54M | $34.53M | $34.52M | $31.75M | $31.75M | $31.71M | $31.71M | $30.00M | $29.98M | $29.90M |
| Common share repurchases | $358.00K | $394.00K | $16.92M | $1.56M | $258.00K | $621.00K | $25.98M | $1.54M | $68.00K | $134.00K |
| Depreciation & amortization | $2.65M | $2.61M | $2.57M | $2.54M | $2.52M | $2.38M | $2.36M | $2.42M | $2.34M | $2.27M |
Derived
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $19.98M | Unavailable | Unavailable | $776.00K | $52.60M | -$69.77M | Unavailable | $33.15M | $24.22M | $27.14M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 32.4% | 34.6% | 34.4% | 28.0% | 34.5% | 31.8% | 33.6% | 35.3% | 33.7% | 31.5% |
| FCF margin | 12.7% | Unavailable | Unavailable | 0.5% | 37.1% | -51.3% | Unavailable | 23.7% | 18.2% | 22.3% |
| SBC / revenue | 6.8% | 7.4% | 7.4% | 7.0% | 8.7% | 8.9% | 8.5% | 7.8% | 10.9% | 11.4% |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 11.1% | 12.2% | 8.3% | 2.9% | 6.4% | 11.8% | 9.6% | 17.3% | 7.7% | 0.9% |
| Net margin | 26.8% | 32.3% | 29.1% | 24.3% | 29.4% | 27.1% | 29.6% | 32.8% | 29.8% | 26.1% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.6% | Unavailable | Unavailable | 0.2% | 1.8% | 1.6% | Unavailable | 1.2% | 1.1% | 3.5% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 27.1% | 22.8% | Unavailable | Unavailable | 25.1% | 22.4% | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CNS in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-10-30View SEC filing
10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
Reconciliation checks needing review
12 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-06-30
Difference 1250000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2025-03-31
Difference 121710000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-09-30
Difference 14491000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-30
Difference 114570000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-03-31
Difference 90909000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 2032000, beyond tolerance 1000000.
cash flow reconciliationreview2023-09-30
Operating, investing and financing flows differ from the reported change in cash by 1320000, beyond tolerance 1000000.
balance equationreview2023-09-30
Difference 84119000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-06-30
Difference 85518000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
cash flow reconciliationreview2023-03-31
Operating, investing and financing flows differ from the reported change in cash by 1409000, beyond tolerance 1000000.
balance equationreview2023-03-31
Difference 87249000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.